TABLE 1

Patients with Malignant Lesions

Lesion no.Patient’s age (y)Patient’s sexLesion size (cm)/locationFollow-up/pathologySUV1*SUV2% Change
178F2.5/RLLAdenocarcinoma (Bx)3.104.0029.0
271M2.0/LULAdenocarcinoma (Res)1.121.3318.8
379M4.2/RULAdenocarcinoma (Res)4.645.5619.1
475M3.0/RULAdenocarcinoma (Bx)4.725.3814.0
573F2.4 × 2.1/LLL§SCC (Bx)8.3410.5326.3
61.8/LLL|SCC (Bx)4.585.9730.3
769F1.5/RULAdenocarcinoma (Bx)1.692.1829.0
875M2.0/LULAdenocarcinoma (Res)1.221.3611.5
963F1.8 × 1.0/RLLAdenocarcinoma (Bx)1.451.7218.6
1088F3.5 × 5.0/LLLAdenocarcinoma (Bx)7.068.2416.7
1183M3.4 × 2.7/RULAdenocarcinoma (Res)3.094.2738.2
1254F0.6/LULProbable lung cancer: no Bx, but response to XRT2.803.2114.6
1373F1.7 × 1.4/RULSCC (Res)2.602.8710.4
1470F6.0/RULSCC (Res)5.235.9313.4
1571M3.5 × 2.5/LULMetastasis from prostate cancer (Bx)2.572.9012.8
1667M2.5/RMLAdenocarcinoma (Bx)2.543.0821.3
1768M4.0 × 3.0/LULAdenocarcinoma (Bx)3.354.3630.1
1871F1.9 × 1.2/RULSCC (Bx)3.634.0812.4
1983F2.8 × 2.7/LULAdenocarcinoma (Bx)3.123.5614.1
2067F3.0 × 3.0/RULAdenocarcinoma (Res)6.258.0428.6
  • * Mean ± SD of SUV1 = 3.66 ± 1.95.

  • Mean ± SD of SUV2 = 4.43 ± 2.43.

  • Mean = 20.5%.

  • § Lesion 1.

  • | Lesion 2.

  • RLL = right lower lobe; Bx = biopsy; LUL = left upper lobe; Res = surgical resection; RUL = right upper lobe; LLL = left lower lobe; SCC = squamous cell carcinoma; XRT = x-ray therapy; RML = right middle lobe.